A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients - Related Studies

A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

This study has been completed.

Study NCT00000991. Last updated on August 25, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pneumonia, Pneumocystis Carinii
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Pneumonia
		Pneumonia, Pneumocystis

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Lung Diseases
		Lung Diseases, Fungal
		Mycoses
		Pneumocystis Infections
		Respiratory Tract Diseases
		Respiratory Tract Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Pentamidine isethionate
		Sulfamethoxazole-Trimethoprim
		Dapsone
		Zidovudine

5	Additional drug interventions recognized in this trial
		Pentamidine
		Sulfamethoxazole
		Trimethoprim
		Trimethoprim-Sulfamethoxazole Combination

6	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Infective Agents, Urinary
		Anti-Retroviral Agents
		Antifungal Agents
		Antimalarials
		Antimetabolites
		Antiparasitic Agents
		Antiprotozoal Agents
		Antiviral Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Leprostatic Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Renal Agents
		Reverse Transcriptase Inhibitors
		Therapeutic Uses
		Trypanocidal Agents

7	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)